CFM
CRL icon

Capricorn Fund Managers’s Charles River Laboratories CRL Stock Holding History

Capricorn Fund Managers’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.09M Buy
+31,274
New +$5.57M 0.56% 53

Other funds holding CRL

BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return
CPCPP
Canada Post Corporation Pension Plan Toronto, Canada $2.87B AUM 37.96% 1-Year Est. Return

Capricorn Fund Managers's CRL Position: Q2 2026 in Review

Capricorn Fund Managers opened a new position in Charles River Laboratories (CRL) in Q2 2026: 31,274 shares worth $7.09M. The stake represents 0.56% of the portfolio and ranks #53 among its holdings.

105 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Capricorn Fund Managers held 31,274 shares of Charles River Laboratories worth $7.09M as of Q2 2026.
  • Charles River Laboratories was a new Capricorn Fund Managers position in Q2 2026.
  • Charles River Laboratories made up 0.56% of Capricorn Fund Managers's portfolio in Q2 2026, its #53 holding.
  • 105 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Capricorn Fund Managers's 13F filing for Q2 2026, filed 24 Jul 2026.